Seasonality Snapshot

Incyte (INCY)

Biotech · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
SEASONAL TAILWIND — July
Strongest Month
November
+5.00% avg · 67% win rate
Weakest Month
September
-4.75% avg · 27% win rate
MonthAvg ReturnWin Rate
January +3.78% 69%
February +0.21% 44%
March +0.32% 44%
April +0.84% 50%
May +2.61% 75%
June +3.11% 69%
July NOW +1.49% 63%
August +3.00% 53%
September -4.75% 27%
October +3.32% 47%
November +5.00% 67%
December +0.26% 40%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Incyte seasonality — common questions

What is Incyte's best month historically?
Historically, November has been Incyte's strongest month, averaging +5.00% with a 67% win rate over 15 years of data. September has been the weakest at -4.75%.
Is Incyte seasonal?
Incyte shows a measurable seasonal pattern: its best and worst months differ by 9.75 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Incyte historically perform in July?
Incyte is currently in July, which has historically averaged +1.49% with a 63% win rate. That has historically been a seasonally favourable window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.